SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 492 filers reported holding SEAGEN INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,826,059,060 | +10.3% | 13,321,042 | +0.0% | 0.07% | +13.1% |
| Q2 2023 | $2,562,731,538 | -3.9% | 13,315,658 | +1.1% | 0.06% | -10.3% |
| Q1 2023 | $2,666,118,683 | +60.3% | 13,167,969 | +1.7% | 0.07% | +51.1% |
| Q4 2022 | $1,663,571,974 | -4.0% | 12,945,078 | +2.2% | 0.04% | -11.8% |
| Q3 2022 | $1,732,699,000 | -21.6% | 12,663,152 | +1.4% | 0.05% | -17.7% |
| Q2 2022 | $2,210,539,000 | +25.0% | 12,493,151 | +1.7% | 0.06% | +47.6% |
| Q1 2022 | $1,768,813,000 | -5.8% | 12,279,156 | +1.1% | 0.04% | -2.3% |
| Q4 2021 | $1,876,849,000 | -8.5% | 12,140,039 | +0.5% | 0.04% | -15.7% |
| Q3 2021 | $2,050,619,000 | +8.8% | 12,076,668 | +1.2% | 0.05% | +8.5% |
| Q2 2021 | $1,884,386,000 | +13.4% | 11,935,558 | -0.3% | 0.05% | +4.4% |
| Q1 2021 | $1,662,170,000 | -20.1% | 11,970,117 | +0.7% | 0.04% | -25.0% |
| Q4 2020 | $2,081,587,000 | – | 11,885,283 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |